
AriBio and Fujirebio Complete Sample Set for Alzheimer’s Biomarker Partnership
AriBio and Fujirebio Reach Key Milestone in Alzheimer’s Biomarker Research with Completion of Sample Collection from Phase 3 Trial Fujirebio Holdings Inc., along with its wholly owned subsidiary Fujirebio Diagnostics, Inc., and biopharmaceutical company AriBio Co., Ltd., has announced the…











